Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2015

Open Access 01-12-2015 | Research article

Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital

Authors: Jin mei Luo, Shan Li, Hui Huang, Jian Cao, Kai Xu, Ya lan Bi, Rui e Feng, Cheng Huang, Ying zhi Qin, Zuo jun Xu, Yi Xiao

Published in: BMC Pulmonary Medicine | Issue 1/2015

Login to get access

Abstract

Background

Thorax is the common place to develop Castleman disease (CD), but there is no systemic clinical analysis for intrathoracic CD.

Methods

We conducted a retrospective analysis of 48 intrathoracic CD patients with definite pathological diagnosis who were hospitalized between 1992 and 2012 in a Chinese tertiary referral hospital.

Results

The study included 16 cases with unicentric CD (UCD) and 32 cases with multicentric CD (MCD). UCD were younger than MCD (30.5y vs 41.6ys, P < 0.05). MCD were more symptomatic (50% vs 96.9%, P < 0.001) and sicker than UCD, including more fever, hepatomegaly and/or splenomegaly and hypoalbuminemia. All of UCD showed solitary mass in various sites and two of them were complicated by small pleural effusion. In the MCD group, their chest CT showed obvious lymphadenopathy in the hilum and/or mediastinum (100%), diffuse parenchymal lung shadows (43.75%), pleural effusion (40.6%), mass in the mediastinum (6.25%) or hilum (3.12%) and bronchiolitis obliterans (BO) (3.12%). Besides LIP-like images, multiple nodules of different size and sites, patchy, ground-glass opacities and consolidation were showed in their chest CT. Surgery were arranged for all UCD for diagnosis and treatment and all were alive. In MCD group, superficial lymph nodes biopsies (21 cases), surgery biopsy (9 cases) and CT-guided percutaneous lung biopsy (2 cases) were performed. Hyaline vascular (HV) variant were more common in the UCD group (75% vs 37.5%, P < 0.05). In MCD group, 28 cases were prescribed with chemotherapy, one refused to receive therapy and the rest three were arranged for regular follow-up. Among MCD, 18 cases was improved, 7 cases was stable, 4 cases lost follow-up and 3 cases died.

Conclusions

Intrathoracic MCD was more common than UCD in our hospital. MCD was older, more symptomic and sicker than UCD. HV variant were more common in UCD. All of UCD showed mass in various intrathoracic locations and surgery resection was performed for all and all were alive. Mass, pleural effusion, BO and diffuse pulmonary shadows, including LIP-like images, multiple nodules of different size and sites, patchy, GGO and consolidations were showed in our MCD. Most of MCD cases were arranged with chemotherapy and their prognosis were worse than UCD’s.
Literature
1.
go back to reference Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, et al. The clinical spectrum of Castleman’s disease. Am J Hematol. 2012;87:997–1002.CrossRefPubMedPubMedCentral Dispenzieri A, Armitage JO, Loe MJ, Geyer SM, Allred J, Camoriano JK, et al. The clinical spectrum of Castleman’s disease. Am J Hematol. 2012;87:997–1002.CrossRefPubMedPubMedCentral
3.
go back to reference Zhu SH, Yu YH, Zhang Y, Sun JJ, Han DL, Li J. Clinical features and outcome of patients with HIV-negative multicentric Castleman’s disease treated with combination chemotherapy: a report on 10 patients. Med Oncol. 2013;30:492.CrossRefPubMed Zhu SH, Yu YH, Zhang Y, Sun JJ, Han DL, Li J. Clinical features and outcome of patients with HIV-negative multicentric Castleman’s disease treated with combination chemotherapy: a report on 10 patients. Med Oncol. 2013;30:492.CrossRefPubMed
4.
go back to reference Kim JH, Jun TG, Sung SW, Shim YS, Han SK, Kim YW, et al. Giant lymph node hyperplasia (Castleman’s disease) in the chest. Ann Thorac Surg. 1995;59:1162–5.CrossRefPubMed Kim JH, Jun TG, Sung SW, Shim YS, Han SK, Kim YW, et al. Giant lymph node hyperplasia (Castleman’s disease) in the chest. Ann Thorac Surg. 1995;59:1162–5.CrossRefPubMed
5.
go back to reference Ko SF, Wan YL, Ng SH, Lin JW, Hsieh MJ, Fang FM, et al. Imaging features of atypical thoracic Castleman disease. Clin Imaging. 2004;28:280–5.CrossRefPubMed Ko SF, Wan YL, Ng SH, Lin JW, Hsieh MJ, Fang FM, et al. Imaging features of atypical thoracic Castleman disease. Clin Imaging. 2004;28:280–5.CrossRefPubMed
6.
go back to reference Kwon S, Lee KS, Ahn S, Song I, Kim TS. Thoracic Castleman disease: computed tomography and clinical findings. J Comput Assist Tomogr. 2013;37:1–8.CrossRefPubMed Kwon S, Lee KS, Ahn S, Song I, Kim TS. Thoracic Castleman disease: computed tomography and clinical findings. J Comput Assist Tomogr. 2013;37:1–8.CrossRefPubMed
7.
go back to reference Burrah R, Deshmane V, Althaf S, Yapamakula S, Kurubabala S, Hanumaiah A, et al. Castleman’s disease of the pleura. Gen Thorac Cardiovasc Surg. 2011;59:572–4.CrossRefPubMed Burrah R, Deshmane V, Althaf S, Yapamakula S, Kurubabala S, Hanumaiah A, et al. Castleman’s disease of the pleura. Gen Thorac Cardiovasc Surg. 2011;59:572–4.CrossRefPubMed
8.
go back to reference Yu JY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, et al. Castleman’s disease presenting as a tracheal mass. Ann Thorac Surg. 2014;97:1798–800.CrossRefPubMed Yu JY, Oh IJ, Kim KS, Kim YI, Lim SC, Kim YC, et al. Castleman’s disease presenting as a tracheal mass. Ann Thorac Surg. 2014;97:1798–800.CrossRefPubMed
9.
go back to reference Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman’s disease. Br J Dermatol. 2003;149:1143–51.CrossRefPubMed Nikolskaia OV, Nousari CH, Anhalt GJ. Paraneoplastic pemphigus in association with Castleman’s disease. Br J Dermatol. 2003;149:1143–51.CrossRefPubMed
10.
go back to reference Chin AC, Stich D, White FV, Radhakrishnan J, Holterman MJ. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of Castleman’s disease with respiratory failure requiring lung transplantation. J Pediatr Surg. 2001;36:E22.PubMed Chin AC, Stich D, White FV, Radhakrishnan J, Holterman MJ. Paraneoplastic pemphigus and bronchiolitis obliterans associated with a mediastinal mass: a rare case of Castleman’s disease with respiratory failure requiring lung transplantation. J Pediatr Surg. 2001;36:E22.PubMed
11.
go back to reference Awotedu AA, Otulana BA, Ukoli CO. Giant lymph node hyperplasia of the lung (Castleman’s disease) associated with recurrent pleural effusion. Thorax. 1990;45:775–6.CrossRefPubMedPubMedCentral Awotedu AA, Otulana BA, Ukoli CO. Giant lymph node hyperplasia of the lung (Castleman’s disease) associated with recurrent pleural effusion. Thorax. 1990;45:775–6.CrossRefPubMedPubMedCentral
12.
go back to reference Ko SF, Ng SH, Hsieh MJ, Lin JW, Huang CC, Lee TY, et al. Castleman disease of the pleura: experience with eight surgically proven cases. Ann Thorac Surg. 2003;76:219–24.CrossRefPubMed Ko SF, Ng SH, Hsieh MJ, Lin JW, Huang CC, Lee TY, et al. Castleman disease of the pleura: experience with eight surgically proven cases. Ann Thorac Surg. 2003;76:219–24.CrossRefPubMed
13.
go back to reference Gunluoglu G, Olcmen A, Sokucu SN, Akin H, Dincer I. Intrapulmonary-located Castleman’s disease, which was surgically resected without pulmonary resection. Ann Thorac Cardiovasc Surg. 2011;17:580–3.CrossRefPubMed Gunluoglu G, Olcmen A, Sokucu SN, Akin H, Dincer I. Intrapulmonary-located Castleman’s disease, which was surgically resected without pulmonary resection. Ann Thorac Cardiovasc Surg. 2011;17:580–3.CrossRefPubMed
14.
go back to reference Hwangbo Y, Cha SI, Lee YH, Lee SY, Seo H, Oh S, et al. A case of multicentric Castleman’s disease presenting with follicular bronchiolitis. Tuberc Respir Dis (Seoul). 2013;74:23–7.CrossRef Hwangbo Y, Cha SI, Lee YH, Lee SY, Seo H, Oh S, et al. A case of multicentric Castleman’s disease presenting with follicular bronchiolitis. Tuberc Respir Dis (Seoul). 2013;74:23–7.CrossRef
15.
go back to reference Johkoh T, Muller NL, Ichikado K, Nishimoto N, Yoshizaki K, Honda O, et al. Intrathoracic multicentric Castleman disease: CT findings in 12 patients. Radiology. 1998;209:477–81.CrossRefPubMed Johkoh T, Muller NL, Ichikado K, Nishimoto N, Yoshizaki K, Honda O, et al. Intrathoracic multicentric Castleman disease: CT findings in 12 patients. Radiology. 1998;209:477–81.CrossRefPubMed
16.
go back to reference Iyonaga K, Ichikado K, Muranaka H, Fujii K, Yamaguchi T, Suga M. Multicentric Castleman’s disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide. Intern Med. 2003;42:182–6.CrossRefPubMed Iyonaga K, Ichikado K, Muranaka H, Fujii K, Yamaguchi T, Suga M. Multicentric Castleman’s disease manifesting in the lung: clinical, radiographic, and pathologic findings and successful treatment with corticosteroid and cyclophosphamide. Intern Med. 2003;42:182–6.CrossRefPubMed
17.
go back to reference Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670–83.CrossRefPubMed Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670–83.CrossRefPubMed
18.
go back to reference Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16:236–46.CrossRefPubMed Cronin DM, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol. 2009;16:236–46.CrossRefPubMed
19.
go back to reference Shin DY, Jeon YK, Hong YS, Kim TM, Lee SH, Kim DW, et al. Clinical dissection of multicentric Castleman disease. Leuk Lymphoma. 2011;52:1517–22.CrossRefPubMed Shin DY, Jeon YK, Hong YS, Kim TM, Lee SH, Kim DW, et al. Clinical dissection of multicentric Castleman disease. Leuk Lymphoma. 2011;52:1517–22.CrossRefPubMed
20.
go back to reference Ye B, Gao SG, Li W, Yang LH, Zhao SH, Ma K, et al. A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients. Med Oncol. 2010;27:1171–8.CrossRefPubMed Ye B, Gao SG, Li W, Yang LH, Zhao SH, Ma K, et al. A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patients. Med Oncol. 2010;27:1171–8.CrossRefPubMed
21.
go back to reference Milanovic N, Matkovic S, Ristic D, Jelic S, Petrovic M. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma. J BUON. 2012;17:497–501.PubMed Milanovic N, Matkovic S, Ristic D, Jelic S, Petrovic M. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma. J BUON. 2012;17:497–501.PubMed
22.
go back to reference De Marchi G1, De Vita S, Fabris M, Scott CA, Ferraccioli G. Systemic connective tissue disease complicated by Castleman’s disease: report of a case and review of the literature. Haematologica. 2004;89:ECR03.PubMed De Marchi G1, De Vita S, Fabris M, Scott CA, Ferraccioli G. Systemic connective tissue disease complicated by Castleman’s disease: report of a case and review of the literature. Haematologica. 2004;89:ECR03.PubMed
23.
go back to reference Guihot A, Couderc LJ, Agbalika F, Galicier L, Bossi P, Rivaud E, et al. Pulmonary manifestations of multicentric Castleman’s disease in HIV infection: a clinical, biological and radiological study. Eur Respir J. 2005;26:118–25.CrossRefPubMed Guihot A, Couderc LJ, Agbalika F, Galicier L, Bossi P, Rivaud E, et al. Pulmonary manifestations of multicentric Castleman’s disease in HIV infection: a clinical, biological and radiological study. Eur Respir J. 2005;26:118–25.CrossRefPubMed
24.
go back to reference Guihot A, Couderc LJ, Rivaud E, Galicier L, Bossi P, Oksenhendler E, et al. Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patients. J Thorac Imaging. 2007;22:207–11.CrossRefPubMed Guihot A, Couderc LJ, Rivaud E, Galicier L, Bossi P, Oksenhendler E, et al. Thoracic radiographic and CT findings of multicentric Castleman disease in HIV-infected patients. J Thorac Imaging. 2007;22:207–11.CrossRefPubMed
25.
go back to reference McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA. Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology. 1998;209:221–8.CrossRefPubMed McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA. Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology. 1998;209:221–8.CrossRefPubMed
26.
go back to reference Sheng L, Cao WK. HIV/AIDS epidemiology and prevention in China. Chin Med J (Engl). 2008;121:1230–6. Sheng L, Cao WK. HIV/AIDS epidemiology and prevention in China. Chin Med J (Engl). 2008;121:1230–6.
27.
go back to reference Robinson Jr D, Reynolds M, Casper C, Dispenzieri A, Vermeulen J, Payne K, et al. Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres. Br J Haematol. 2014;165:39–48.CrossRefPubMed Robinson Jr D, Reynolds M, Casper C, Dispenzieri A, Vermeulen J, Payne K, et al. Clinical epidemiology and treatment patterns of patients with multicentric Castleman disease: results from two US treatment centres. Br J Haematol. 2014;165:39–48.CrossRefPubMed
28.
go back to reference Waterston A, Bower M. Fifty years of multicentric Castleman’s disease. Acta Oncol. 2004;43:698–704.CrossRefPubMed Waterston A, Bower M. Fifty years of multicentric Castleman’s disease. Acta Oncol. 2004;43:698–704.CrossRefPubMed
29.
go back to reference Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, et al. Clinical features and treatment of multicentric castleman’s disease: a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop. 2013;53:69–77.CrossRefPubMed Kawabata H, Kadowaki N, Nishikori M, Kitawaki T, Kondo T, Ishikawa T, et al. Clinical features and treatment of multicentric castleman’s disease: a retrospective study of 21 Japanese patients at a single institute. J Clin Exp Hematop. 2013;53:69–77.CrossRefPubMed
30.
go back to reference Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3–17.CrossRefPubMed Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol. 2005;129:3–17.CrossRefPubMed
31.
go back to reference Dossier A, Meignin V, Fieschi C, Boutboul D, Oksenhendler E, Galicier L. Human herpesvirus 8-related Castleman disease in the absence of HIV infection. Clin Infect Dis. 2013;56:833–42.CrossRefPubMed Dossier A, Meignin V, Fieschi C, Boutboul D, Oksenhendler E, Galicier L. Human herpesvirus 8-related Castleman disease in the absence of HIV infection. Clin Infect Dis. 2013;56:833–42.CrossRefPubMed
32.
go back to reference Kurai M, Kondo R, Kobayashi N, Hyogotani A, Yoshida K, Amano J. Castleman’s disease arising from the chest wall. Jpn J Thorac Cardiovasc Surg. 2006;54:555–7.CrossRefPubMed Kurai M, Kondo R, Kobayashi N, Hyogotani A, Yoshida K, Amano J. Castleman’s disease arising from the chest wall. Jpn J Thorac Cardiovasc Surg. 2006;54:555–7.CrossRefPubMed
33.
go back to reference Ueda H, Kouso H, Tsukamoto S. Castleman’s disease of the chest wall. J Thorac Oncol. 2009;4:426–8.CrossRefPubMed Ueda H, Kouso H, Tsukamoto S. Castleman’s disease of the chest wall. J Thorac Oncol. 2009;4:426–8.CrossRefPubMed
34.
go back to reference Pham TT, Harrell JH, Harrell JH, Herndier B, Yi ES. Endotracheal castleman disease: a case report. Chest. 2007;131:590–2.CrossRefPubMed Pham TT, Harrell JH, Harrell JH, Herndier B, Yi ES. Endotracheal castleman disease: a case report. Chest. 2007;131:590–2.CrossRefPubMed
35.
go back to reference Pinheiro VG, Fernandes GH, Cezar LC, Alves NA, de Menezes DB. Castleman’s disease accompanied by pleural effusion. J Bras Pneumol. 2008;34:626–30.CrossRefPubMed Pinheiro VG, Fernandes GH, Cezar LC, Alves NA, de Menezes DB. Castleman’s disease accompanied by pleural effusion. J Bras Pneumol. 2008;34:626–30.CrossRefPubMed
36.
go back to reference Jindal T, Meena M, Kumar A, Khaitan BK. Paraneoplastic pemphigus with Castleman’s disease and bronchiolitis obliterans. Pediatr Int. 2011;53:1108–9.CrossRefPubMed Jindal T, Meena M, Kumar A, Khaitan BK. Paraneoplastic pemphigus with Castleman’s disease and bronchiolitis obliterans. Pediatr Int. 2011;53:1108–9.CrossRefPubMed
38.
go back to reference Gupta NK, Torigian DA, Gefter WB, Marshall MB, Liang H, Carver JR, et al. Mediastinal Castleman disease mimicking mediastinal pulmonary sequestration. J Thorac Imaging. 2005;20:229–32.CrossRefPubMed Gupta NK, Torigian DA, Gefter WB, Marshall MB, Liang H, Carver JR, et al. Mediastinal Castleman disease mimicking mediastinal pulmonary sequestration. J Thorac Imaging. 2005;20:229–32.CrossRefPubMed
39.
go back to reference Slater BJ, Nordin AB, Allen CE, Elghetany MT, Heinle JS, Kim ES. Resection of mediastinal castleman’s disease: a case report. Pediatr Hematol Oncol. 2013;30:554–6.CrossRefPubMed Slater BJ, Nordin AB, Allen CE, Elghetany MT, Heinle JS, Kim ES. Resection of mediastinal castleman’s disease: a case report. Pediatr Hematol Oncol. 2013;30:554–6.CrossRefPubMed
40.
go back to reference Stavridis GT, Lau OJ. Castleman’s disease arising from the intercostal space. Eur J Cardiothorac Surg. 1993;7:218–9.CrossRefPubMed Stavridis GT, Lau OJ. Castleman’s disease arising from the intercostal space. Eur J Cardiothorac Surg. 1993;7:218–9.CrossRefPubMed
41.
go back to reference Yeh CM, Chou CM, Wong LC. Castleman’s disease mimicking intrapulmonary malignancy. Ann Thorac Surg. 2007;84:e6–7.CrossRefPubMed Yeh CM, Chou CM, Wong LC. Castleman’s disease mimicking intrapulmonary malignancy. Ann Thorac Surg. 2007;84:e6–7.CrossRefPubMed
42.
go back to reference Blankenship ME, Rowlett J, Timby JW, Roth RS, Jones RE. Giant lymph node hyperplasia (Castleman’s disease) presenting with chylous pleural effusion. Chest. 1997;112:1132–3.CrossRefPubMed Blankenship ME, Rowlett J, Timby JW, Roth RS, Jones RE. Giant lymph node hyperplasia (Castleman’s disease) presenting with chylous pleural effusion. Chest. 1997;112:1132–3.CrossRefPubMed
43.
go back to reference Light RW. The Light criteria: the beginning and why they are useful 40 years later. Clin Chest Med. 2013;34:21–6.CrossRefPubMed Light RW. The Light criteria: the beginning and why they are useful 40 years later. Clin Chest Med. 2013;34:21–6.CrossRefPubMed
Metadata
Title
Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital
Authors
Jin mei Luo
Shan Li
Hui Huang
Jian Cao
Kai Xu
Ya lan Bi
Rui e Feng
Cheng Huang
Ying zhi Qin
Zuo jun Xu
Yi Xiao
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2015
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-015-0019-x

Other articles of this Issue 1/2015

BMC Pulmonary Medicine 1/2015 Go to the issue